UNII 4VON5FNS3C

SODIUM METABISULFITE

Unique Ingredient Identifier 4VON5FNS3C is listed as a ingredient substance
Unii4VON5FNS3C
Preferred Substance NameSODIUM METABISULFITE
Rn7681-57-4
Ec231-673-0
NcitC77498
Rxcui36696
Molecular Formula2Na.O5S2
InchikeyHRZFUMHJMZEROT-UHFFFAOYSA-L
Smiles[Na+].[Na+].[O-]S(=O)S([O-])(=O)=O
Unii TypeINGREDIENT SUBSTANCE
RN7681-57-4
EC231-673-0
NCITC77498
RXCUI36696
MF2Na.O5S2
INCHI KEYHRZFUMHJMZEROT-UHFFFAOYSA-L
SMILES[Na+].[Na+].[O-]S(=O)S([O-])(=O)=O

Alternate Names

Dosage Forms

UNII 4VON5FNS3C SODIUM METABISULFITE is commonly included in medications in the following forms.

RouteDosage FormPotency
AN,CNBLK INTRATHECALINJECTION NA
AN,INFILTRATIONINJECTION0.5 %
CAUDAL BLOCKINJECTION0.18 %
DENTALINJECTION0.05 %
EPIDURALINJECTION0.18 %
IM - IV - SCINJECTION0.15 %
IM - IV - SCSOLUTION, INJECTION NA
INFILTRATIONINJECTION0.05 %
INHALATIONSOLUTION1 %
INTRA-ARTICULARINJECTION0.2 %
INTRABURSALINJECTION0.2 %
INTRACARDIACINJECTION0.09 %
INTRACARDIACSOLUTION, INJECTION NA
INTRAMUSCULARINJECTION27.5 %W/V
INTRAMUSCULARINJECTION1.8 MG/1ML
INTRAMUSCULARSOLUTION, INJECTION0.66 %W/V
INTRAPERITONEALINJECTION0.33 %
INTRAVENOUSEMULSION, INJECTION0.025 %
INTRAVENOUSINJECTION9 MG/1ML
INTRAVENOUSINJECTION0.32 %
INTRAVENOUSSOLUTION, INJECTION0.66 %
INTRAVENOUS INFUSIONINJECTION2 mg/1mL
IONTOPHORESISPATCH, CONTROLLED RELEASE0.5 MG
IONTOPHORESISSOLUTION0.05 %
IV(INFUSION)INJECTION1.1 %
IV(INFUSION)INJECTION1 MG/1ML
IV(INFUSION)SOLUTION, INJECTION0.22 %
NERVE BLOCKINJECTION0.5 %
NERVE BLOCKSOLUTION, INJECTION0.05 %
OPHTHALMICSOLUTION0.25 %
OPHTHALMICSUSPENSION, DROPS0.1 %
ORALCAPSULE0.36 MG
ORALCONCENTRATE2 MG/1ML
ORALLIQUID1 MG/5ML
ORALORAL SOLUTION DOSAGE FORM1 mg/5mL
ORALSOLUTION320 MG/160ML
ORALSOLUTION5 MG/5ML
ORALSUSPENSION5 MG/5ML
ORALSUSPENSION, EXTENDED RELEASE5 MG/5ML
ORALSYRUP1 MG/1ML
ORALTABLET8 MG
PERIDURALINJECTION NA
RECTALTABLET2 MG
SUBCUTANEOUSINJECTION1.2 mg/1mL
SUBCUTANEOUSINJECTION0.3 %
SUBCUTANEOUSSOLUTION, INJECTION0.05 %
SUBLINGUALTABLET2 MG
SUBMUCOSALINJECTION0.05 %
SUBMUCOSALSOLUTION, INJECTION5 %
TOPICALCREAM, AUGMENTED0.2 %W/W
TOPICALEMULSION, CREAM NA
TOPICALLOTION0.2 %W/V
TOPICALPATCH0.002 MG
TOPICALPATCH, CONTROLLED RELEASE0.5 MG
TOPICALPOWDER, FOR SOLUTION NA
TOPICALSUSPENSION0.3 %W/W
VAGINALSPONGE1.5 MG

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.